SCHEMBL29659560

SCHEMBL29659560

Cc1ccc(CNc2nc(Cl)nc3c2ncn3C2CCCCO2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ YTHDC1 Q96MU7 1/20 0.68
▸ NPC1 O15118 2/20 0.60
▸ RAB9A P51151 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.60
▸ CTSL P07711 1/20 0.48
▸ CDK1 P06493 2/20 0.47
▸ CYP1A2 P05177 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ CCNE2 O96020 1/20 0.47
▸ CCNE1 P24864 1/20 0.47
▸ CDK2 P24941 1/20 0.47
▸ ADORA3 P0DMS8 4/20 0.47
▸ ADORA1 P30542 2/20 0.47
▸ ADORA2A P29274 1/20 0.47
▸ TSHR P16473 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ GMNN O75496 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ LMNA P02545 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20547206 1.00 YTHDC1 (0.68) YTHDC1NPC1RAB9ASMN1; SMN2CTSL
SCHEMBL20547202 0.90 YTHDC1 (0.65) YTHDC1NPC1RAB9ASMN1; SMN2CTSL
SCHEMBL1501479 0.90 NPC1 (0.73) YTHDC1NPC1RAB9ASMN1; SMN2CTSL
SCHEMBL29659561 0.90 NPC1 (0.73) YTHDC1NPC1RAB9ASMN1; SMN2CTSL
SCHEMBL29659669 0.90 YTHDC1 (0.64) YTHDC1NPC1RAB9ASMN1; SMN2CTSL
SCHEMBL5763160 0.90 YTHDC1 (0.64) YTHDC1NPC1RAB9ASMN1; SMN2CTSL
SCHEMBL30410510 0.89 NPC1 (0.60) YTHDC1NPC1RAB9ASMN1; SMN2CTSL
SCHEMBL20547443 0.88 YTHDC1 (0.62) YTHDC1NPC1RAB9ASMN1; SMN2CTSL
SCHEMBL29659511 0.88 YTHDC1 (0.62) YTHDC1NPC1RAB9ASMN1; SMN2CTSL
SCHEMBL20547488 0.87 YTHDC1 (0.60) YTHDC1NPC1RAB9ASMN1; SMN2CTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3615535-B1 9-(2-OXACYCLOALKYL)-9H-PURINE-2,6-DIAMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SKIN DISORDERS UNIV PALACKEHO (CZ) 2022-06-15 — — EP disclosed
Send feedback